Development pharmaceutics for veterinary medicinal products

Current effective version

PDF iconAdopted guideline

Reference numberEMEA/CVMP/315/98
Effective from01/03/2000
KeywordsDevelopment pharmaceutics, formulation, quality, product, dosage form, veterinary medicinal product (VMP)
DescriptionThis document provides guidance on the data from pharmaceutical development studies required for marketing authorisation of veterinary medicinal products. It applies to pharmaceuticals produced by chemical synthesis.

Related content


How useful was this page?

Add your rating